EYP-1901 for Wet Age-Related Macular Degeneration

EYP-1901 for Wet Age-Related Macular Degeneration
56%45%34%May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 28May 27 • YES 45.0%
EyePoint Pharmaceuticals, Inc. ($EYPT)
No stock close$13.79$12.60$11.41May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 28May 18 • EYPT $11.70May 19 • EYPT $11.82May 20 • EYPT $12.50May 21 • EYPT $12.78May 22 • EYPT $12.93May 26 • EYPT $13.35May 27 • EYPT $13.16May 28 • EYPT $13.50

Will this trial show a positive result on Average change in best corrected visual acuity (BCVA), Weeks 52 and 56?

Paper Trading
Create account to trade
ClinicalNewsTrialPositionsReasoningOracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs